TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03927534

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful Eating
Description: The ME group will be composed by 7 weekly group sessions with a minimum duration of two hours, mixing theoretical contents with practices. Sessions will always be the same day of the week, except for bank holidays or eventualities, and will be conducted by a psychologist specially trained and certified in ME with experience in leading mindfulness groups. Group sizes will range between 10 and 12 participants. At the end of each session, participants will receive theoretical contents and homework activities to be practiced along the week.
Study: NCT02237495

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dexmedetomidine
Description: dexmedetomidine with the dose of 0.4 ug/kg/h is continuously infused right after anesthesia induction and lasts for 12 hrs.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: The vehicle of dexmedetomidine, normal saline is continuously infused right after anesthesia induction and lasts for 12 hrs with the same rate of the treatment arm.
Study: NCT02786355

Intervention type: OTHER
Group type: OTHER
Intervention: Frova bougie
Description: Squeezing an Ambu bag and delivering air through a Frova bougie. Measuring mean volumes of air delivered and peak pressures generated.

Intervention type: OTHER
Group type: OTHER
Intervention: Frova bougie
Description: Squeezing an Ambu bag and delivering air through a Frova bougie. Measuring mean volumes of air delivered and peak pressures generated.
Study: NCT04558645

Intervention type: OTHER
Intervention: Online Survey
Description: Online surveys will be applied to all participants

Intervention type: OTHER
Intervention: Online Survey
Description: Online surveys will be applied to all participants
Study: NCT00320385

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lapatinib
Description: oral lapatinib once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lapatinib
Description: oral lapatinib once daily

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: IV trastuzumab 2mg/kg weekly after 4mg/kg loading dose
Study: NCT01830452

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Self-fixating Parietex Progrip Mesh
Description: Lichtenstein hernioplasty using a self fixating Parietex Progrip mesh not needing any fixating devices

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Self-fixating Parietex Progrip Mesh
Description: Lichtenstein hernioplasty using a self fixating Parietex Progrip mesh not needing any fixating devices
Study: NCT00615940

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: WX-671
Description: capsules taken per os once daily until progression or toxicity

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo
Description: capsule taken per os once daily until progression or toxicity
Study: NCT03105440

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality
Description: This virtual reality of projection software, which uses Kinact®, captures the patient's picture and transfers to the monitor. The exercises provided by game are similar to those performed in conventional therapy; however, in a more entertaining form.~Comprised 8 exercises to upper limbs and trunk. The patient should reach the red circle until it becomes green.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vibration therapy
Description: The vibration mat used in this study was developed by the members of the Laboratory of Sensory and Motor Engineering Rehabilitation together with mark Vibra Ind. e Com. Prod. Electronics Ltda.~Will participate 20 woman, that stay in supine position, with the enveloped member of the vibration mat, elevated and supported. The volunteer will be submitted to 15 minutes of vibration with frequency of the 40 hertz, in both upper limbs.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hand cycling
Description: Will participate 20 woman, submitted hand cycling through of the adapted bicycle to upper members. The protocol will be comprised by track without obstacle, comprised by 10 turns. The cyclic movement velocity will be realized according to the physical fatigue of patients.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Canoeing
Description: Will participate 20 woman, submitted canoeing activates, through rowing realized in therapeutic pool, with the aid and supervision of the therapeutic. It is important highlight that the exercises intensity will be to realized according to the physical fatigue of patients.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Robotic rehabilitation
Description: It Will be used a exoskeleton Armeo®Spring, to training to affected upper limb, the protocol of the treatment is constituted for 8 games. The equipment arm will be adjusted the volunteers height, in sitting position, allowing support against the action of gravity of the arm and forearm, supporting 45° of the shoulder flexion, which will be facilitation the member movement.
Study: NCT01669564

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Will use HIT patient feedback to activate patients.
Description: After completing the FAST, GIMO patients seeing a participating provider will receive(or not receive)HIT patient feedback, based on their providers' study group assignment. Feedback for each PRI will be personalized based on the medical history, family history, and other PRI reported on the FAST. A discussion of potential treatment options will be presented along with possible general referral resources. The patient will be encouraged to discuss the PRI with his or her physician.~Patients will be provided with a list of resources, customized to their study-designated PRI, that includes ongoing programs available both in the community and GIMO to help them with behavior change and mental HRQoL.

Intervention type: OTHER
Group type: OTHER
Intervention: Will use HIT patient feedback to activate patients.
Description: After completing the FAST, GIMO patients seeing a participating provider will receive(or not receive)HIT patient feedback, based on their providers' study group assignment. Feedback for each PRI will be personalized based on the medical history, family history, and other PRI reported on the FAST. A discussion of potential treatment options will be presented along with possible general referral resources. The patient will be encouraged to discuss the PRI with his or her physician.~Patients will be provided with a list of resources, customized to their study-designated PRI, that includes ongoing programs available both in the community and GIMO to help them with behavior change and mental HRQoL.

Intervention type: OTHER
Group type: OTHER
Intervention: Patients will not receive HIT patient feedback.
Description: After completing the FAST (standard of care in GIMO) GIMO patients seeing a participating provider will receive (or not receive) HIT patient feedback, based on their providers' study group assignment.
Study: NCT04223349

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-70033093
Description: JNJ-70033093 capsules will be administered orally .

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-70033093
Description: JNJ-70033093 capsules will be administered orally .

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-70033093
Description: JNJ-70033093 capsules will be administered orally .

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo in capsule will be administered orally.
Study: NCT01669564

Intervention type: OTHER
Group type: OTHER
Intervention: Patients will not receive HIT patient feedback.
Description: After completing the FAST (standard of care in GIMO) GIMO patients seeing a participating provider will receive (or not receive) HIT patient feedback, based on their providers' study group assignment.
Study: NCT00281073

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intra-Cardiac Echocardiography guided Cardioversion
Description: Intracardiac Echo and TEE
Study: NCT03105440

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control group
Description: Will participate 20 healthy woman, that won't pass to the treatment physiotherapeutic, only will be collected the electromyography and dynamometer.
Study: NCT02320799

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: interpersonal psychotherapy
Description: Interpersonal psychotherapy is an evidence based, structured, brief psychotherapy which improves relationships in order to improve mood and reduce anxiety
Study: NCT01793233

Intervention type: OTHER
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Ancillary studies
Study: NCT03778697

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic Sleeve Gastroplasty
Description: Endoscopic full-thickness suture system to plicate the greater curvature of the stomach
Study: NCT00859274

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: budesonide
Description: Budesonide is given via inhalation utilising a dry powder inhaler called Easyhaler. The dosage is 400 ug twice daily. The duration of the study is 12 weeks but very probably the patients continue the usage of this drug as a part of their routine clinical management.
Study: NCT04223349

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo in capsule will be administered orally.
Study: NCT00281073

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intracardiac Echo
Description: Intracardiac Echo Viewmate
Study: NCT04223349

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo in capsule will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo in capsule will be administered orally.
Study: NCT04062565

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treprostinil Injectable Product
Description: Injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Riociguat Pill
Description: Tablet
Study: NCT00281073

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ICE
Description: ICE or TEE

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ICE
Description: ICE or TEE
Study: NCT00594503

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy
Description: Total body exposure to increased atmospheric pressure oxygen
Study: NCT02913755

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preparatory video
Description: 5 minute Preparatory video to increase motivation, awareness and engagement in ABI rehabilitation
Study: NCT04457973

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active tDCS
Description: tDCS with a constant current intensity of 2 milliampere (mA) will be applied for 20 minutes per session daily for 5 days via the Soterix 1x1 tDCS mini-CT Stimulator device with headgear and 5x7 cm saline-soaked surface sponge electrodes.
Study: NCT02913755

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Preparatory video
Description: 5 minute Preparatory video to increase motivation, awareness and engagement in ABI rehabilitation
Study: NCT00916045

Intervention type: DRUG
Group type: OTHER
Intervention: Thiotepa

Intervention type: DRUG
Group type: OTHER
Intervention: Fludarabine

Intervention type: DRUG
Group type: OTHER
Intervention: Intravenous busulphan

Intervention type: DRUG
Group type: OTHER
Intervention: Thymoglobulin

Intervention type: DRUG
Group type: OTHER
Intervention: Ciclosporin

Intervention type: DRUG
Group type: OTHER
Intervention: Mycophenolate mofetil (MMF)

Intervention type: DRUG
Group type: OTHER
Intervention: Fludarabine
Study: NCT02320799

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: treatment as usual
Description: Clinic psychosocial treatment as usual
Study: NCT04090931

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment
Description: leveling and aligning stage in orthodontics
Study: NCT00916045

Intervention type: DRUG
Group type: OTHER
Intervention: Cyclophosphamide

Intervention type: RADIATION
Group type: OTHER
Intervention: Radiotherapy

Intervention type: DRUG
Group type: OTHER
Intervention: Thymoglobulin

Intervention type: DRUG
Group type: OTHER
Intervention: Ciclosporin
Study: NCT04457973

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham tDCS
Description: The electrodes will be placed in the same positions as for active stimulation, but the stimulator will only deliver 2 mA current for 30 seconds.
Study: NCT00916045

Intervention type: DRUG
Group type: OTHER
Intervention: Mycophenolate mofetil (MMF)

Intervention type: DRUG
Group type: OTHER
Intervention: Fludarabine

Intervention type: DRUG
Group type: OTHER
Intervention: Melphalan
Study: NCT00218725

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Cognitive Therapy
Description: The cognitive therapy intervention for suicide attempters has been designed to provide a brief, timely, flexible intervention that can be incorporated into general and psychiatric inpatient and outpatient services and applied to the population of patients who attempt suicide. A central feature of the intervention is the adaptation of cognitive therapy to the population of patients who attempt suicide. The focus of the intervention is the identification of core beliefs and key automatic thoughts that were elicited prior to and during the most recent suicide attempt. Once these beliefs and thoughts have been articulated, the counselor and patient develop more adaptive responses during an acute suicidal crisis.

Intervention type: OTHER
Group type: OTHER
Intervention: Enriched Care
Description: The Enriched Care condition will be used as the treatment comparison condition for this study. The Enriched Care condition consists of the usual care that patients may obtain in the community as well as the assessment and referral services provided by the case managers. Participation in the study does not restrict patients in any way in their access to other health care, and all patients in both conditions will be allowed to receive any additional mental health and substance abuse treatment in the community.
Study: NCT03262402

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Basic periodontal treatment
Description: Basic periodontal treatment consists of scaling and root planing performed with manual curettes or ultrasonic instruments.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Basic periodontal treatment
Description: Basic periodontal treatment consists of scaling and root planing performed with manual curettes or ultrasonic instruments.
Study: NCT04087928

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FMV_flex
Description: Fisiocomputer EVM (Endomedica, Italy) for application of FMV to flexor muscles of the upper limb (brachial biceps and carpal flexors).

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FMV_ext
Description: Fisiocomputer EVM (Endomedica, Italy) for application of FMV to extensors muscles of the upper limb (triceps brachial and carpus extensors).
Study: NCT01577654

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EC145
Description: 2.5 mg on Days 1,4,8,11 (Weeks 1 and 2 q3 weeks)
Study: NCT03719560

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: Systemic methotrexate
Study: NCT00916045

Intervention type: DRUG
Group type: OTHER
Intervention: Thymoglobulin

Intervention type: DRUG
Group type: OTHER
Intervention: Ciclosporin
Study: NCT01577654

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EC145 + Docetaxel
Description: EC145 2.5 mg on Days 1,4,8,11 (Weeks 1 and 2 q3 weeks) +~Docetaxel 75 mg/m2 IV Day 1 q 3 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel
Description: 75 mg/m2 IV Day 1 q 3 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EC20
Description: During the screening period participants will receive a single intravenous administration of EC20 prior to SPECT imaging
Study: NCT00916045

Intervention type: DRUG
Group type: OTHER
Intervention: Mycophenolate mofetil (MMF)
Study: NCT01577654

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EC20
Description: During the screening period participants will receive a single intravenous administration of EC20 prior to SPECT imaging

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: EC20
Description: During the screening period participants will receive a single intravenous administration of EC20 prior to SPECT imaging
Study: NCT01905111

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 853520
Description: BI 853520 once daily in a dose escalation schedule
Study: NCT03346707

Intervention type: DEVICE
Intervention: 10.5 Tesla
Description: 10.5Tesla MR scan
Study: NCT04756180

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omega-3-acid ethyl ester or Placebo
Description: Omega-3-acid ethyl ester 2 gm/day for first 4 week followed by 4gm/day for 8 week

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Omega-3-acid ethyl ester or Placebo
Description: Omega-3-acid ethyl ester 2 gm/day for first 4 week followed by 4gm/day for 8 week
Study: NCT00977808

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Closed-Loop, Model Predictive Control (MPC)
Description: Subjects used the OmniPod Insulin Management System (Insulet Corp.) and Insulin lispro (Eli Lilly, Indianapolis, IN). MPC algorithm suggested insulin boluses every 15 min, which, if accepted, were programmed into the insulin pump by the attending physician. Otherwise, the admission remained the same as in the open-loop admission (i.e. meals, sleep, etc...).

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Open-Loop
Description: This admission was to assess the subjects' level of glucose control and created a base to compare the performance of the closed-loop system. Subjects monitored their own blood glucose values and administer their basal/bolus as they would at home. Subjects used their own insulin pumps and Insulin lispro (Eli Lilly, Indianapolis, IN). Otherwise, the admission remained the same as in the closed-loop admission (i.e. meals, sleep, etc...).
Study: NCT02822391

Intervention type: OTHER
Intervention: observation

Intervention type: OTHER
Intervention: observation
Study: NCT02194608

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home telehealth system
Description: Participants will receive a weighing machine, glucometer, and a sphygmomanometer connected through a Bluetooth system from their home to the Telehealth center via a HUB.
Study: NCT02253238

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Symptoms Surveys
Description: Behavioral: Symptoms survey 1; completed at weeks 1, 3, 5, and 7 days after RT, and at 6 - 8 weeks after RT.~Behaviorial: Symptoms survey 2; completed at baseline, weeks 1, 3, 5, and 7 days after RT, and at 6 - 8 weeks after RT.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Symptoms Surveys
Description: Behavioral: Symptoms survey 1; completed at weeks 1, 3, 5, and 7 days after RT, and at 6 - 8 weeks after RT.~Behaviorial: Symptoms survey 2; completed at baseline, weeks 1, 3, 5, and 7 days after RT, and at 6 - 8 weeks after RT.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Device Usability Survey
Description: Device usability survey; completed at weeks 1, 3, 5, and 7 days after RT.
Study: NCT02018796

Intervention type: DRUG
Intervention: Mifepristone, misoprostol
Description: 200 mifepristone, followed 24 to 48 hours later by 600 mcg misoprostol
Study: NCT03548155

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Berberine
Description: Berberine 300mg（three times a day） plus any atypical antipsychotic drug

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: atypical antipsychotic
Description: Any atypical antipsychotic drug as the basic treatment

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: atypical antipsychotic
Description: Any atypical antipsychotic drug as the basic treatment

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: The placebo were matched to Berberine in shape, smell and colour and capsules were sealed in identical bottles
Study: NCT00709514

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DCB-WH1 ointment
Description: DCB-WH1 ointment (1.25%), topically applied twice daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT02676973

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open, Robotic, or Laparoscopic
Description: Sacral Colpopexy is a surgery performed either through an incision in the abdomen or through several small incisions with the help of a laparoscope (a slender tube) or robot. The surgery is done with a permanent synthetic (man-made) mesh. The mesh is sutured (stitched) to the vagina and sacrum (tail bone) and is used as reinforcement. It provides additional support to weakened tissues and/or muscles.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transvaginal Native Tissue Repair
Description: Transvaginal Native Tissue Repair is a surgery performed with an incision through the vagina (transvaginal). The surgery is done using both permanent and absorbable sutures (stitches), to support weakened tissue and/or muscles, and attach the top of the vagina to ligaments in the pelvis (either to the sacrospinous ligament or uterosacral ligament).

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Uphold™ LITE
Description: Transvaginal Mesh Repair is a surgery performed with an incision through the vagina (transvaginal). The surgery is done with a permanent synthetic (man-made) mesh. The mesh is attached to ligaments in the pelvis and is used to reinforce natural tissue and/or muscles, which are no longer able to provide support to the vagina.
Study: NCT00684801

Intervention type: OTHER
Intervention: questionnaire administration
Description: Patients complete questionnaires.

Intervention type: OTHER
Intervention: questionnaire administration
Description: Patients complete questionnaires.

Intervention type: PROCEDURE
Intervention: quality-of-life assessment
Description: Patients undergo quality-of-life assessments.

Intervention type: PROCEDURE
Intervention: quality-of-life assessment
Description: Patients undergo quality-of-life assessments.
Study: NCT04092595

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-06651600
Description: PF-06651600: 200 mg dose provided as four 50 mg oral tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: 10 mg oral tablet
Study: NCT03617419

Intervention type: DEVICE
Group type: OTHER
Intervention: GE VScan Access R2 Ultrasound System
Description: A diagnostic ultrasound imaging system manufactured by the study Sponsor.

Intervention type: DEVICE
Group type: OTHER
Intervention: GE Corometrics 170 Series Fetal Monitor
Description: A reference device to record a continuous fetal heart rate.

Intervention type: DEVICE
Group type: OTHER
Intervention: GE Corometrics 170 Series Fetal Monitor
Description: A reference device for verification of scanning the fetal heart.